Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Matter

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
Nature Methods|January 9, 2023
Robust single-cell matching and multimodal analysis using shared and distinct featuresBokai Zhu, Shuxiao Chen, Yunhao Bai, et al.
Plos One|April 14, 2017
Vascular endothelial growth factor A amplification in colorectal cancer is associated with reduced M1 and M2 macrophages and diminished PD-1-expressing lymphocytesKatharina Burmeister, Luca Quagliata, Mariacarla Andreozzi, et al.
Hepatology (Baltimore, Md.)|October 12, 2013
Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patientsLuca Quagliata, Matthias S Matter, Salvatore Piscuoglio, et al.
BMC Genomics|August 5, 2021
Multi-omics data integration reveals novel drug targets in hepatocellular carcinomaChristos Dimitrakopoulos, Sravanth Kumar Hindupur, Marco Colombi, et al.
Hepatology Communications|July 24, 2019
Hepatocellular Carcinoma Xenografts Established From Needle Biopsies Preserve the Characteristics of the Originating TumorsTanja Blumer, Isabel Fofana, Matthias S Matter, et al.
Hepatology (Baltimore, Md.)|February 5, 2016
Oncogenic driver genes and the inflammatory microenvironment dictate liver tumor phenotypeMatthias S Matter, Jens U Marquardt, Jesper B Andersen, et al.
Molecular Cancer Therapeutics|April 8, 2011
Pathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib--a phase II trialMonika E Hegi, Annie-Claire Diserens, Pierre Bady, et al.
Oncotarget|April 19, 2017
Adverse genomic alterations and stemness features are induced by field cancerization in the microenvironment of hepatocellular carcinomasDarko Castven, Michael Fischer, Diana Becker, et al.
Cell Systems|December 18, 2017
Resolving the Combinatorial Complexity of Smad Protein Complex Formation and Its Link to Gene ExpressionPhilippe Lucarelli, Marcel Schilling, Clemens Kreutz, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 29, 2026
Optimized Ex Vivo Human Liver Slice Culture Maintains Extended Viability and Function for Hepatotoxicity TestingHuiche Feng, Cinzia Esposito, Andrej Benjak, et al.
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Nature Methods|January 9, 2023
Robust single-cell matching and multimodal analysis using shared and distinct featuresBokai Zhu, Shuxiao Chen, Yunhao Bai, et al.
Plos One|April 14, 2017
Vascular endothelial growth factor A amplification in colorectal cancer is associated with reduced M1 and M2 macrophages and diminished PD-1-expressing lymphocytesKatharina Burmeister, Luca Quagliata, Mariacarla Andreozzi, et al.
Hepatology (Baltimore, Md.)|October 12, 2013
Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patientsLuca Quagliata, Matthias S Matter, Salvatore Piscuoglio, et al.
BMC Genomics|August 5, 2021
Multi-omics data integration reveals novel drug targets in hepatocellular carcinomaChristos Dimitrakopoulos, Sravanth Kumar Hindupur, Marco Colombi, et al.
Hepatology Communications|July 24, 2019
Hepatocellular Carcinoma Xenografts Established From Needle Biopsies Preserve the Characteristics of the Originating TumorsTanja Blumer, Isabel Fofana, Matthias S Matter, et al.
Hepatology (Baltimore, Md.)|February 5, 2016
Oncogenic driver genes and the inflammatory microenvironment dictate liver tumor phenotypeMatthias S Matter, Jens U Marquardt, Jesper B Andersen, et al.
Molecular Cancer Therapeutics|April 8, 2011
Pathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib--a phase II trialMonika E Hegi, Annie-Claire Diserens, Pierre Bady, et al.
Oncotarget|April 19, 2017
Adverse genomic alterations and stemness features are induced by field cancerization in the microenvironment of hepatocellular carcinomasDarko Castven, Michael Fischer, Diana Becker, et al.
Cell Systems|December 18, 2017
Resolving the Combinatorial Complexity of Smad Protein Complex Formation and Its Link to Gene ExpressionPhilippe Lucarelli, Marcel Schilling, Clemens Kreutz, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 29, 2026
Optimized Ex Vivo Human Liver Slice Culture Maintains Extended Viability and Function for Hepatotoxicity TestingHuiche Feng, Cinzia Esposito, Andrej Benjak, et al.
Pageof 11